Lendlease stock faces funding risk after sale deadline moves

Published on 10/07/2026 at 03:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lendlease stock faced a 15 October deadline for the MSG North sale after conditions remained unmet. FY2026 revenue rose 29 percent to AUD 3.9 billion.

Lendlease, AU000000LLC3, Illustration mit AI erstellt.

Lendlease stock (ISIN AU000000LLC3) was at AUD 2.56 on the ASX on October 5, 2026, down 3.03 percent for the session. The key issue is the delayed sale of the MSG North development in Milan, which now carries a potential AUD 160 million funding requirement.

MSG North deadline moves

As Motley Fool reported on October 2, 2026, Lendlease and Bizzi & Partners extended the deadline for satisfying the sale conditions to October 15, 2026. The transaction concerns Lendlease's interest in the Milano Santa Giulia project through its Heartbeat Fund.

The transaction outcome directly affects funding visibility. If the sale does not complete, Lendlease may need to fund AUD 160 million of project obligations in the first half of fiscal year 2027, according to Motley Fool.

Revenue growth meets balance sheet pressure

Lendlease's FY2026 revenue increased 29 percent to AUD 3.9 billion from fiscal year 2025, while new work secured rose 28 percent to AUD 6.4 billion. Those figures came from the company's FY2026 earnings call published by Yahoo Finance on September 16, 2026.

The earnings mix remains uneven. Construction delivered an EBITDA margin of 4.3 percent in FY2026, while statutory loss after tax reached AUD 749 million and reported gearing stood at 30.3 percent, according to Yahoo Finance. The contrast leaves execution on major projects and asset sales as the central stock question.

Consensus target stays above price

A seven-analyst consensus published by Investing.com assigned Lendlease a Neutral rating, with three Buy ratings, three Holds and one Sell. The average 12-month target was AUD 3.593, with a high of AUD 4.50 and a low of AUD 2.92.

Against the ASX price of AUD 2.56 on October 5, 2026, the consensus target lies 40.4 percent above the price. That comparison is conditional on the MSG North transaction and the group's ability to convert its AUD 6.4 billion work pipeline into cash generation.

Lendlease stock weighs the next deadline

Lendlease stock was at AUD 2.56 on the ASX on October 5, 2026, with a daily change of -3.03 percent. The October 15, 2026, MSG North deadline is the next concrete test for funding visibility.